NewTradingView.com – Investing and Stock News
Investing and Stock News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Editor's Pick

Biden DHS’s purchase of weapon linked to Havana Syndrome attacks leads House Republicans to demand answers

by January 16, 2026
written by January 16, 2026

The Biden administration purchased a pulsed energy weapon suspected of being the type that may have caused ‘Havana Syndrome’ which caused a series of mysterious ailments for U.S. diplomats and government workers in Cuba. 

The weapon was bought at the end of the Biden Administration and has since been tested by the Pentagon, Fox News has learned. House Republicans are demanding answers amid reports of the purchase of the device.

In a letter to Homeland Security Kristi Noem, House Committee on Homeland Security Chairman Andrew Garbarino, R-N.Y., is asking for information on the procurement process for the weapon, its costs and the findings associated with its year-long testing related to Havana Syndrome, officially known as Anomalous Health Incidents (AHI). 

‘The device in question is described as capable of producing pulsed radio waves and containing Russian components, though it is supposedly not entirely Russian in origin,’ the letter states. ‘Following HSI’s successful acquisition of the device, it was reportedly transferred to DoW, which spent more than a year testing the device and its capabilities.’

Some U.S. intelligence agencies have said a foreign adversary could be behind the mysterious ailment. 

Fox News Digital previously reported that Adam, a former government employee whose identity Fox News agreed to protect, is considered to be ‘Patient Zero.’

He was first attacked in December 2016 while living in Havana on assignment. During his time on the Caribbean island, Adam experienced multiple attacks and described pressure to the brain that led to vertigo, tinnitus and cognitive impairment.

‘While assessments from the Intelligence Community (IC) do not conclusively identify the factors causing AHIs or any foreign actor responsible, an assessment from the Office of the Director of National Intelligence (ODNI) presented a majority view concluding that it was ‘very unlikely’ that a foreign actor ‘used a novel weapon or prototype device to harm even a subset of the U.S. Government personnel,’ with five out of seven agencies agreeing with that assessment,’ Garbarino wrote in his letter. 

‘However, two agencies dissented from the majority view and assessed that there was a chance that foreign actors may have developed some sort of ‘novel weapon or prototype device’ that could have harmed U.S. personnel,’ he added. 

However, the Office of the Director of National Intelligence (ODNI) released the report and held a background call with reporters on Friday explaining that new reporting ‘led two components to shift their assessments about whether a foreign actor has a capability that could cause biological effects consistent with some of the symptoms reported as possible AHIs.’

‘This shift consequently led two IC components to subtly change their overall judgment about whether a foreign actor might have played a role in a small number of events,’ the agency said. 

Fox News’ Liz Friden contributed to this report. 

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Venezuelan opposition leader María Corina Machado presents Nobel medal to Trump despite institute ban
next post
Former Ukrainian PM accused of bribing politicians with US dollars to weaken Zelenskyy’s government

You may also like

Trump’s tariffs could be undone by one conservative...

January 16, 2026

Venezuelan opposition leader María Corina Machado presents Nobel...

January 16, 2026

Former Ukrainian PM accused of bribing politicians with...

January 16, 2026

Dems relent, Senate sends $174B spending package to...

January 15, 2026

Trump’s Greenland takeover would likely entail enormous price...

January 15, 2026

China quietly builds worldwide space network, alarming US...

January 15, 2026

Pompeo says Iranian regime has arrived at ‘natural...

January 15, 2026

Turkey says Syria using force is an option...

January 15, 2026

US sending military assets to Middle East as...

January 15, 2026

White House defends ‘aptly named’ Department of War...

January 15, 2026
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!




    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular Posts

    • 1

      Gold and Silver: Gold remains stable in the $2420 zone

    • 2

      Oil and natural gas: Oil is back on the positive side

    • 3

      The dollar index continues to pull back to a new low

    • 4

      IonQ Stock Review: Should You Consider Investing Now?

    • 5

      Gold Price Surge Hits $3,385 Amid Trade Tensions

    Recent Posts

    • Trump’s tariffs could be undone by one conservative doctrine: ‘Life or death’

      January 16, 2026
    • Former Ukrainian PM accused of bribing politicians with US dollars to weaken Zelenskyy’s government

      January 16, 2026
    • Biden DHS’s purchase of weapon linked to Havana Syndrome attacks leads House Republicans to demand answers

      January 16, 2026
    • Venezuelan opposition leader María Corina Machado presents Nobel medal to Trump despite institute ban

      January 16, 2026
    • Trump’s Greenland takeover would likely entail enormous price tag: report

      January 15, 2026

    Categories

    • Economy (20)
    • Editor's Pick (435)
    • Investing (138)
    • Stock (21)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: NewTradingView.com, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 NewTradingView.com All Rights Reserved.


    Back To Top
    NewTradingView.com – Investing and Stock News
    • Investing
    • Stock
    • Economy
    • Editor’s Pick